Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,122,936
  • Shares Outstanding, K 589,800
  • Annual Sales, $ 6,005 M
  • Annual Income, $ 1,402 M
  • EBIT $ 1,507 M
  • EBITDA $ 1,652 M
  • 60-Month Beta 1.12
  • Price/Sales 7.35
  • Price/Cash Flow 27.08
  • Price/Book 4.69

Options Overview Details

View History
  • Implied Volatility 34.90% ( +0.07%)
  • Historical Volatility 26.06%
  • IV Percentile 75%
  • IV Rank 41.07%
  • IV High 53.15% on 10/16/24
  • IV Low 22.18% on 05/23/24
  • Put/Call Vol Ratio 0.67
  • Today's Volume 4,358
  • Volume Avg (30-Day) 4,924
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 110,952
  • Open Int (30-Day) 123,939

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.55
  • Number of Estimates 12
  • High Estimate 0.57
  • Low Estimate 0.54
  • Prior Year 0.64
  • Growth Rate Est. (year over year) -14.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.35 +7.47%
on 12/02/24
75.27 -0.98%
on 12/20/24
+4.05 (+5.75%)
since 11/22/24
3-Month
64.00 +16.44%
on 10/07/24
75.27 -0.98%
on 12/20/24
+7.17 (+10.64%)
since 09/23/24
52-Week
58.93 +26.47%
on 07/25/24
96.12 -22.46%
on 03/28/24
-1.30 (-1.71%)
since 12/22/23

Most Recent Stories

More News
Is the Options Market Predicting a Spike in Edwards (EW) Stock?

Investors in Edwards Lifesciences Corporation EW need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $45.00 Call had some of the highest...

EW : 74.07 (-0.99%)
Insider Sale: CVP of $EW (EW) Sells 2,500 Shares

Daniel J. Lippis, the CVP of $EW ($EW), sold 2,500 shares of the company on 12-16-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 9.7% of their shares. Following...

EW : 74.07 (-0.99%)
Is Becton, Dickinson and Company Stock Underperforming the Dow?

Becton, Dickinson and Company have underperformed the Dow Jones Industrials Average over the past year, yet Wall Street analysts maintain a bullish outlook on the stock’s prospects.

EW : 74.07 (-0.99%)
BDX : 225.85 (-0.80%)
$DOWI : 42,764.83 (-0.18%)
Insider Sale: CVP of $EW (EW) Sells 11,250 Shares

Scott B. Ullem, the CVP of $EW ($EW), sold 11,250 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 26.9% of their shares. Following...

EW : 74.07 (-0.99%)
Is Edwards Lifesciences Stock Underperforming the S&P 500?

Edwards Lifesciences has recently underperformed the broader S&P 500, yet analysts remain moderately optimistic about the stock's potential.

EW : 74.07 (-0.99%)
$SPX : 5,946.39 (+0.26%)
MDT : 80.50 (-0.65%)
Insider Sale: CVP of $EW (EW) Sells 1,750 Shares

Daveen Chopra, the CVP of $EW ($EW), sold 1,750 shares of the company on 12-06-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 6.0% of their shares. Following...

EW : 74.07 (-0.99%)
Are Wall Street Analysts Predicting Edwards Lifesciences Stock Will Climb or Sink?

Edwards Lifesciences has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

EW : 74.07 (-0.99%)
$SPX : 5,946.39 (+0.26%)
IHI : 58.35 (-0.78%)
Edwards Lifesciences: Q3 Earnings Snapshot

Edwards Lifesciences: Q3 Earnings Snapshot

EW : 74.07 (-0.99%)
Edwards Lifesciences Earnings Preview: What to Expect

Edwards Lifesciences will release its third-quarter earnings this month, and analysts anticipate a double-digit bottom-line growth.

EW : 74.07 (-0.99%)
XLV : 137.62 (-0.28%)
$SPX : 5,946.39 (+0.26%)
Stocks Slightly Higher Before FOMC Decision

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.11%. Stocks today are slightly...

$SPX : 5,946.39 (+0.26%)
SPY : 591.88 (+0.12%)
$DOWI : 42,764.83 (-0.18%)
DIA : 427.15 (-0.32%)
$IUXX : 21,422.53 (+0.63%)
QQQ : 520.66 (+0.39%)
ZNH25 : 108-230 (-0.23%)
SMCI : 31.80 (+0.66%)
CCL : 25.50 (-4.85%)
NCLH : 25.98 (-3.46%)
RCL : 236.81 (-0.68%)
VFC : 21.66 (-2.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair...

See More

Key Turning Points

3rd Resistance Point 78.03
2nd Resistance Point 76.65
1st Resistance Point 75.73
Last Price 74.07
1st Support Level 73.43
2nd Support Level 72.05
3rd Support Level 71.13

See More

52-Week High 96.12
Fibonacci 61.8% 81.91
Fibonacci 50% 77.53
Last Price 74.07
Fibonacci 38.2% 73.14
52-Week Low 58.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar